Comparison of Neoadjuvant Nab-Paclitaxe plus Carboplatin vs Nab-Paclitaxe plus Gemcitabine in Triple-Negative Breast Cancer : Randomized WSG-ADAPT-TN Trial Results

Gluz, Oleg; Nitz, Ulrike; Liedtke, Cornelia; Christgen, Matthias; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Bangemann, Nikola; Lindner, Christoph; Kuemmel, Sherko; Clemens, Michael; Potenberg, Jochem; Staib, Peter; Kohls, Andreas; von Schumann, Raquel; Harbeck, Nadia

Comparison of Neoadjuvant Nab-Paclitaxe plus Carboplatin vs Nab-Paclitaxe plus Gemcitabine in Triple-Negative Breast Cancer : Randomized WSG-ADAPT-TN Trial Results

Author:

Gluz, Oleg; Nitz, Ulrike; Liedtke, Cornelia; Christgen, Matthias; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Bangemann, Nikola; Lindner, Christoph; Kuemmel, Sherko; Clemens, Michael; Potenberg, Jochem; Staib, Peter; Kohls, Andreas; von Schumann, Raquel; Harbeck, Nadia

Tübinger Autor(en):

Grischke, Eva-Maria

Published in:

Jnci - Journal of The National Cancer Institute (2018), Bd. 110, Article djx258, S. 628-637

Verlagsangabe:

Oxford Univ Press Inc

Language:

English

Full text:

http://dx.doi.org/10.1093/jnci/djx258

ISSN:

1460-2105